Insights

Perspective, tips, and resources for moving health forward

All Insights Health Systems Pharmacies Physician Practices Manufacturers Animal Health
AmerisourceBergen

Three questions to ask about your market access partner

Inverted color AmerisourceBergen icon
AmerisourceBergen
December 2022

Manufacturers

Acceleration of innovation in healthcare delivery

Teri' Burnell
Teri Burnell, PharmD; Myra Reinhardt
Biopharma Services
November 2022
Patient and doctor

Manufacturers

Podcast: Conversations around interchangeability and biosimilar entries in new therapeutic categories

Inverted color AmerisourceBergen icon
AmerisourceBergen
September 2022
Interchangeable biosimilars

Manufacturers

Closing the gaps in pre-approval information exchange to accelerate product success and patient access

AmerisourceBergen
September 2022
AB color abstract

Manufacturers

Answering the challenges of rare disease market access with HEOR

AmerisourceBergen
September 2022
Male and female coworker at conference table

Manufacturers

Market access abroad: Three reasons why early planning is critical for HTA countries

AmerisourceBergen
August 2022
Abstract image of Red Color Illuminated Fiber Optics Selective Focus on Blue Background.

Manufacturers

Podcast: Milestones for biosimilars in 2022 and looking ahead to 2023

Inverted color AmerisourceBergen icon
AmerisourceBergen
July 2022
Biosimilars podcast

Manufacturers

Innovative agreements: Exploring alternative payment models

Inverted color AmerisourceBergen icon
AmerisourceBergen
July 2022
innovative agreements

Manufacturers

Why FormularyDecisions® is the right choice for enterprise biopharma payer engagement 

Inverted color AmerisourceBergen icon
Xcenda
July 2022
formulary decisions enterprise man working on computer

Manufacturers

Webinar slides: Navigating Reimbursement and Access Challenges for Novel Cell and Gene Therapies

Tasmina Hydery
June 2022
abstract lines

Orphan drugs: trapped in the lock? A review of the lock system in the Netherlands

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2022
Panama Canal Orphan Drug Lock Article Image

Manufacturers

Differentiate your product with FormularyDecisions®

Inverted color AmerisourceBergen icon
Xcenda
April 2022
Differentiate your product with FormularyDecisions

Manufacturers

Six insights driving the evolution of FormularyDecisions®

Tasmina Hydery; Sara Linnerooth
March 2022
Coworkers at meeting

Webinar: Debunking common PIE misperceptions to enhance your PIE strategy and tactics

Inverted color AmerisourceBergen icon
Xcenda
March 2022

Manufacturers

Essential skills for outsourced field solutions teams

Inverted color AmerisourceBergen icon
AmerisourceBergen
November 2021

Manufacturers

Building your field reimbursement and access team: The translational experience and skills that matter most

Inverted color AmerisourceBergen icon
AmerisourceBergen
September 2021

Manufacturers

eBook: Bringing innovation to market with digital therapeutics

Inverted color AmerisourceBergen icon
Lash Group
August 2021

Manufacturers

Navigating the payer landscape for digital therapeutics

Inverted color AmerisourceBergen icon
Lash Group
June 2021

Manufacturers

Patient support for digital therapeutics: Do's and don'ts for designing your program

Inverted color AmerisourceBergen icon
Lash Group
June 2021

Manufacturers

Work worth doing: Innovative field solutions

Inverted color AmerisourceBergen icon
AmerisourceBergen
June 2021

Manufacturers

Innomar Strategies: 20 years of innovative market access solutions

Inverted color AmerisourceBergen icon
Innomar Strategies
June 2021

Manufacturers

Work worth doing: FormularyDecisions

Laurie Fazio
Xcenda
May 2021

Manufacturers

The essential guide to drug commercialization

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2021

Manufacturers

Podcast: ThinkLive Commercialization 2021

Matt Sarnes, PharmD
Biopharma Services
May 2021

Manufacturers

On-demand webinar: Accelerating access to therapy (a view from the front lines)

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2021
Accelerating access to therapy

Manufacturers

The hidden value of integrated commercialization services: A manufacturer’s perspective

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2021

Manufacturers

Ebook: Strategic partnerships for unlocking product potential

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2021
Strategic partnerships for unlocking product potential ebook

Manufacturers

The Value of Real-World Evidence in Canadian Drug Commercialization: Part 2

Inverted color AmerisourceBergen icon
Innomar Strategies
April 2021

Manufacturers

How to make the most of integrated commercialization solutions

Inverted color AmerisourceBergen icon
AmerisourceBergen
March 2021
AmerisourceBergen manufacturer commercialization strategies

Manufacturers

Strategies for addressing copay accumulators: What manufacturers need to know

Corey Ford
Corey Ford, MHA; Dale Hanna
Xcenda
March 2021
copay accumulator piggy bank

Manufacturers

Webinar: uptake or heartbreak with biosimilars? Progress and perspectives

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2021
Market access professionals

Manufacturers

Pre-launch checklist: What to look for in a commercialization partner

Inverted color AmerisourceBergen icon
AmerisourceBergen
February 2021

Manufacturers

Checklist: Four things to look for in a field services partner

Inverted color AmerisourceBergen icon
Xcenda
February 2021
xcenda field services working on project

Manufacturers

Case study: an innovative field reimbursement program expands patient access

Inverted color AmerisourceBergen icon
Xcenda
January 2021

Manufacturers

Cell and gene therapies: bringing innovation to market

Inverted color AmerisourceBergen icon
AmerisourceBergen
December 2020
Lab tech with DNA

Manufacturers

Pharma in the field: Ashley's story

Inverted color AmerisourceBergen icon
Xcenda
November 2020
Doctor talking to patient

Manufacturers

Pharma in the field: Tierra's story

Inverted color AmerisourceBergen icon
Xcenda
November 2020

Manufacturers

Ebook: Virtual drug commercialization

Inverted color AmerisourceBergen icon
AmerisourceBergen
November 2020

Manufacturers

Is a contact-free clinical trial possible?

Portrait of Mike Sweeney
Mike Sweeney; Kim McLeod, MPH
World Courier
September 2020

Patient support launch guide: novel therapies 

Inverted color AmerisourceBergen icon
Lash Group
September 2020
Man working on a laptop computer

Manufacturers

Is your PIE incomplete?

Inverted color AmerisourceBergen icon
Xcenda
September 2020

Manufacturers

Rethink field services: Three myths keeping access barriers in front of your product

Inverted color AmerisourceBergen icon
Xcenda
August 2020
female_doctor_virtual_visit

Manufacturers

Solving access, reimbursement, and PAP awareness problems

Inverted color AmerisourceBergen icon
Xcenda
August 2020
Male doctor speaking to patient on a tablet

Manufacturers

Pharma in the field: Sales reps vs. reimbursement and access specialists

Inverted color AmerisourceBergen icon
Xcenda
July 2020

Manufacturers

The Future of Payer Engagement: How Pharma Can Break Through

Matt Sarnes, PharmD; Allen Lising
Biopharma Services
June 2020

Manufacturers

The Value of Virtual: How Remote Workshops Can Keep Market Access Efforts Moving

AmerisourceBergen icon
Bre Penzner; Nancy Young
Xcenda
May 2020

Manufacturers

Distant But Engaged: Transitioning to Virtual Training

Inverted color AmerisourceBergen icon
Xcenda
May 2020

Manufacturers

Mind the (Evidence) Gap

Kim McLeod
Kim McLeod, MPH
Xcenda
February 2020

Manufacturers

InnomarLive 2019: Commercializing in Canada

Inverted color AmerisourceBergen icon
Innomar Strategies
December 2019

Manufacturers

Biosimilars: Market Insights and Growth Factors

Sean McGowan; Rick Lozano
AmerisourceBergen
September 2019

The growth of biosimilars presents a significant opportunity to reduce the cost of care and provide patients with greater access to affordable treatments. Our experts assess the current state and future of the biosimilars market.

Manufacturers

Biosimilars: Launch Insights From the Field

Inverted color AmerisourceBergen icon
Xcenda
September 2019

How are biosimilar manufacturers approaching patients, providers and payers? What can they do to differentiate? Xcenda shares insight from our field programs.

Manufacturers

How Digital Innovation Drives Improved Market Access Strategies

Inverted color AmerisourceBergen icon
Xcenda
July 2019

In this digital age, how can pharmaceutical manufacturers leverage innovative tools to prove their product's value proposition and overcome market access challenges?

Health Systems

Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies

Inverted color AmerisourceBergen icon
AmerisourceBergen
April 2019

Download this new white paper from IHOC - Coordinated Care: The Value of Patient and Provider Satisfaction within Health System Specialty Pharmacies - to learn the key insights about the role HSSPs play in improving the patient experience and why patient and provider satisfaction are important data points for both payers and manufacturers to consider when deciding to include HSSPs in their networks.

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part Two

Ana Stojanovska
Biopharma Services
June 2018

An executive Q&A on the role of data and the future of innovative reimbursement modeling for cell and gene therapies.

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part One

Ana Stojanovska
Biopharma Services
June 2018

An executive Q&A on challenges and opportunities related to reimbursement, coding and coverage for cell and gene therapies.

Infographic: The Road to Commercialization in Canada

Inverted color AmerisourceBergen icon
AmerisourceBergen
May 2018

Manufacturers

What Do Payers Think About Digital Health Technologies

Inverted color AmerisourceBergen icon
AmerisourceBergen
September 2017

How are payers thinking about apps, wearables and other digital health technologies?

Manufacturers

The Route to Market Access in Canada

Inverted color AmerisourceBergen icon
Innomar Strategies
September 2017

Understanding the unique considerations for reimbursement in the Canadian pharmaceutical market.